Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
2.600
-0.040 (-1.52%)
At close: Mar 28, 2025, 4:00 PM
2.355
-0.245 (-9.42%)
Pre-market: Mar 31, 2025, 8:00 AM EDT
Acelyrin Market Cap
Acelyrin has a market cap or net worth of $261.85 million as of March 31, 2025. Its market cap has decreased by -67.35% in one year.
Market Cap
261.85M
Enterprise Value
-178.73M
1-Year Change
-67.35%
Ranking
Category
Stock Price
$2.60
Market Cap Chart
Since the IPO on May 5, 2023, Acelyrin's market cap has decreased from $1.67B to $261.85M, a decrease of -84.31%. That is a compound annual growth rate of -62.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 261.85M | -16.88% |
| Dec 31, 2024 | 315.02M | -56.62% |
| Dec 29, 2023 | 726.15M | -56.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |